ReviewFrontiers in cellular and infection microbiology2026
The interplay between recovery and immunity in infectious and non-communicable diseases.
Review in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The interplay between recovery and immune responses is increasingly recognized but remains under-integrated in clinical and research frameworks. Recovery extends beyond physiological repair to include restoration of function, psychological adaptation, and social reintegration, while immunity provides dynamic protection and regulation. Emerging evidence suggests that recovery trajectories shape immune competence and long-term resilience. Scope and approach: This review synthesizes evidence on bidirectional recovery-immunity interactions across infectious and non-communicable diseases (NCDs). We examine immune- linked mechanisms of inflammation resolution, tissue repair/regeneration, and functional restoration, and discuss how recovery states feedback to immune competence. Illustrative contexts include viral, bacterial, parasitic, and fungal infections, as well as cancer, autoimmune, metabolic, cardiovascular, and neurodegenerative disorders. Key findings: Shared pathways connecting recovery and immunity include cytokine signaling, macrophage polarization, and regenerative programs. Recovery outcomes are further modified by host and contextual factors such as genetics, aging, nutrition, comorbidities, and psychosocial stress. Clinical and translational approaches, such as immunotherapy, rehabilitation, vaccination, and precision medicine, offer practical ways to support recovery, but they must be applied with careful attention to the immune trade-offs they may introduce. Advances in biomarkers, multi- omics profiling, and AI-enabled modeling offer promising tools to quantify recovery phenotypes and predict immune resilience. Conclusion: Positioning recovery as an active immunological state enables more coherent frameworks for understanding disease trajectories and guiding interventions. Integrating recovery biology with immune regulation may enhance patient outcomes and support durable, resilient health across diverse disease settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.